MGC Derma’s skincare balm demonstrates positive outcome in clinical study

MGC Pharmaceuticals has reported positive results from the final phase of its dermatological skincare product Herbal Repair balm's clinical programme.

Under the DermaPlus range of MGC Derma brand, the balm is being developed to provide daily care for oily and acne prone skin. The clinical study was designed to evaluate the safety and efficacy of the topical product in 90 subjects over three months. It was conducted by Dr Rok Devjak at a dermatological clinic in Slovenia, Europe.

MGC also evaluated other products in the DermaPlus range, including Herbal Replenishing cream for mild seborrheic dermatitis and Herbal Repair cream for psoriasis.

Results showed that the Herbal Repair balm improved oily indications in skin, with an 80% improvement observed in acne prone skin. Around 92% of the subjects noted they would be willing to continue using the cream after the study.

MGC Pharmaceuticals' co-founder and managing director Nativ Segev said: “We are exceptionally pleased that our DermaPlus product range has demonstrated such strong results through these clinical tests.

“Validating the use of medicinal cannabis through rigorous clinical tests is vital to our business model and with more than 50 products still in development, these positive results gives us a glimpse into the exciting potential for our product range.”

The results also indicated a 73% improvement in reducing psoriatic plaques, an 86% improvement in reducing irritated skin, and a more than 70% improvement in minimising the appearance of redness and dryness in skin.

Based on the results, the company can now claim the product softens and smoothems rough skin, improves the appearance of blemished prone skin, is suitable for red and sensitive skin, and prevents development of acne, for marketing purposes.

The positive results are expected to help the product gain a dermatologically tested label. The firm intends to begin commercialisation of the DermaPlus range in Q3 of this year through established distribution channels, new distribution agreements, and an online eShop.